0
2019
Biomarker Technologies Market

Biomarker Technologies Market

by Product (Consumables, and Instruments), Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, and Others), and Application (Drug Discovery, Diagnostics, and Personalized Medicine), and Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026

Report Code: A04930
Pages: 255
Tables: 145
Charts: 58
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Biomarker Technologies Market Outlook - 2026

The biomarker technologies market accounted for $21,594 million in 2018, and is expected to reach $58,508 million by 2026, registering a CAGR of 13.2% from 2019 to 2026. 

Biomarker is a biological characteristic which is measured and evaluated as a maker of normal biological or pathological processes or a response to a therapeutic intervention. For instance, patterns of gene expression are used to identify various diseases. There are different biomarkers, which can be identified by using different technologies such as polymerase chain reaction, next generation sequencing, immunoassay, and others. Biomarkers are extensively used in diagnosis of various diseases such as cancer, infectious diseases, autoimmune diseases, and others. This is due to their property of marking the biological changes associated with these diseases. Moreover, biomarkers are also employed in the drug development process as these can mark early toxicity associated with drugs in the early phases of drug development. In addition, as these provide sensitive data related to disease progression, biomarkers are also employed in personalized medicine. 

The global biomarker technologies market is expected to witness significant growth during the forecast period, owing to increase in prevalence of various diseases and rise in R&D activities in healthcare coupled with surge in adoption of early toxicity testing. In addition, advantages offered by biomarker in drug development and increase in genome mapping programs. However, high initial capital investments required for biomarker discovery, and lack of awareness regarding the use of biomarker technologies hamper the growth of biomarker technologies market. Furthermore, high potential of the emerging economies is expected to provide opportunities for the growth of the biomarker technologies market during the forecast period.

Biomarker Technologies Market Segmentation  

The biomarker technologies market is segmented based on product, technology, application, indication, and region to provide a detailed assessment of the market. Based on product & service, the market is divided into consumables, instruments, and services. The consumables segment is further bifurcated into reagents and assays. Based on technology, the market is divided into polymerase chain reaction, next generation sequencing, immunoassays, and others. Based on application, the market is classified into drug discovery, diagnostics, and personalized medicine. Based on indication, the market is divided into cancer, infectious diseases, autoimmune disorders, cardiovascular disorders, and others. Based on region, the biomarker technologies market size is analyzed across North America (U.S., Canada and Mexico), Europe (Germany, France, the UK, Italy, Spain and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa and rest of LAMEA).

Biomarker Technologies Market

Segment review

Based on product & service, the market is divided into consumables, instruments, and services. The consumables segment was the largest contributor to the biomarker technologies market in 2018 and is expected to maintain its dominant position throughout the analysis period. Consumables are crucial part of biomarker testing and are required for performing various technologies. Therefore, this leads to the growth of this market. On the other side, the instruments segment is the fastest growing segment during the forecast period, owing to the technological advancements, which have rendered these instruments more precise and quick. Moreover, the rise in adoption of biomarker technologies across various fields of science is another factor that contributes to the biomarker technologies market growth. 

Biomarker Technologies Market by Product

According to the biomarker technologies market analysis, the technology segment is classified into polymerase chain reaction (PCR), next generation sequencing (NGS), immunoassay, and others. The immunoassay segment occupied the highest share of the biomarker technologies market size in 2018. Next generation sequencing (NGS) segment registered fastest growth rate during the forecast period, owing to surge in research related to cancer as next generation sequencing is applied in analyzing differences between cancers that otherwise seem identical.

Biomarker Technologies Market by Technology

Region wise, Asia-Pacific accounted for the largest biomarker technologies market share in 2018 owing to surge in R&D related to drug discovery, easy availability of instruments and consumables, availability of trained technicians and high prevalence of diseases such as cancer and autoimmune diseases. Asia-Pacific is expected to register the fastest growth during the forecast period due to rise in awareness related to early screening of cancer for better treatment, increase in disposable income, and surge in R&D investments related to healthcare.

Biomarker Technologies Market by Region

The report provides an extensive competitive analysis and profiles of the key market players such as Agilent Technologies, Inc., Bio-Rad Laboratories, Inc.,  F. Hoffmann-La Roche AG, Illumina, Inc., LI-COR, Inc., Merck KGAA, PerkinElmer Inc., QIAGEN, Shimadzu Corporation, and Thermo Fisher Scientific, Inc.

Key Benefits for Biomarker Technologies Market:

  • This report entails a detailed quantitative analysis along with the current biomarker technologies market trends of the market from 2018 to 2026 to identify the prevailing opportunities along with the strategic assessment of the global market. 
  • The biomarker technologies market forecast is studied from 2019 to 2026. 
  • The market size and estimations are based on a comprehensive analysis of key developments in the biomarker technologies industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

Biomarker Technologies Market Report Highlights

Aspects Details
By PRODUCT AND SERVICES
  • Consumables
    • Reagents
    • Assays
  • Instruments
By Technology
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Immunoassay
  • Others
By Application
  • Drug Discovery
  • Diagnostics
  • Personalized Medicine
By Indication
  • Cancer
  • Infectious Diseases
  • Autoimmune Disorders
  • Cardiovascular Disorders
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players AGILENT TECHNOLOGIES, INC., PERKINELMER INC., Thermo Fisher Scientific, Inc., Shimadzu Corporation, F. HOFFMANN-LA ROCHE LTD., Merck KGAA, LI-COR, Inc., QIAGEN N.V., Illumina, Inc., BIO-RAD LABORATORIES, INC.
 

Loading Table Of Content...


 
 

Biomarker technologies are the techniques used to measure biomarkers. These biomarkers are further measured to examine biological state or condition of the body. They are extensively used in disease identification as these are traceable when introduced into an organism. Moreover, these biomarkers are also employed in the detection of cellular defects and can be used to create genetic maps of the organisms that are studied. Biomarkers are used to detect diseases such as cancers, diabetes, AIDS, and others. The technologies performed to discover biomarkers include polymerase chain reactions (PCR), immunoassay, mass spectroscopy, chromatography, and others. The rise in prevalence of cancer and infectious diseases is the major factor that boosts the growth of the global biomarker technologies market. 

In addition, surge in healthcare investments worldwide is another major factor that drives the market growth. Moreover, increase in adoption of personalized medicine and rise in investments related to drug discovery across the globe are some other factors that contribute toward the growth of this market. However, higher initial capital investment for the discovery of biomarkers and dearth of skilled technical professionals is expected to restrain the market growth. Surge in awareness of early detection for the treatment of cancer makes way for different growth opportunities for the market during the forecast period.

North America garnered the largest share of this market due to rise in research activities related to drug development, easy availability of biomarker product & service, and surge in adoption of personalized medicine in the region.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
Related Tags

Purchase Full Report of
Biomarker Technologies Market

Start reading instantly.
This Report and over 71,297+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (May 2020 - May 2021)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2020 - May 2021)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2020 - May 2021)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2020 - May 2021)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2020 - May 2021)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers